Dr. Laufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2975 Donnylane Blvd
Columbus, OH 43235Phone+1 614-366-8380Fax+1 614-366-8557
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 1975 - 1976- Ohio State University HospitalResidency, Internal Medicine, 1974 - 1975
UPMC Medical EducationResidency, Internal Medicine, 1972 - 1974
University of Pittsburgh School of MedicineClass of 1972
Certifications & Licensure
OH State Medical License 1976 - 2016
Clinical Trials
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer Start of enrollment: 2003 Oct 01
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
Publications & Presentations
PubMed
- 360 citationsRandomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer With...Joaquim Bellmunt, Hans von der Maase, Graham M. Mead, Iwona Skoneczna, Maria De Santis
Journal of Clinical Oncology. 2012-04-01 - 1 citationsPrimary androgen deprivation therapy in men with prostate cancer.Leslie Laufman
JAMA. 2009-01-07 - 191 citationsIntravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving ChemotherapyDavid H. Henry, Naomi V. Dahl, Michael Auerbach, Simon Tchekmedyian, Leslie R. Laufman
The Oncologist. 2007-02-01
Grant Support
- Cancer Information ExchanceNational Cancer Institute1998
- Cancer Information Exchange (CIX)National Cancer Institute1997
- Columbus Community Clinical Oncology ProgramNational Cancer Institute1995–1996
- Columbus Community Clincal Oncology ProgramNational Cancer Institute1991–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
